We are live on
!
Find out more
MCM
McKinley Capital Management Portfolio holdings
AUM
$571M
1-Year Est. Return
36.44%
This Fund
S&P 500
This Quarter
Est. Return
+8.16%
1 Year Est. Return
+36.44%
3 Year Est. Return
+63.3%
5 Year Est. Return
+224.69%
10 Year Est. Return
+727.58%
AUM
$571M
AUM Growth
-$261M
(-31%)
Cap. Flow
-$297M
Cap. Flow
% of AUM
-51.9%
Top 10 Holdings %
Top 10 Hldgs %
42.54%
Holding
165
New
2
Increased
33
Reduced
80
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southern Copper
SCCO
|
+$2.74M |
| 2 |
Agnico Eagle Mines
AEM
|
+$2.52M |
| 3 |
Merck
MRK
|
+$1.09M |
| 4 |
Pinduoduo
PDD
|
+$1.05M |
| 5 |
Ares Capital
ARCC
|
+$766K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$11.2M |
| 2 |
UnitedHealth
UNH
|
+$11.1M |
| 3 |
McKesson
MCK
|
+$10.1M |
| 4 |
Intuitive Surgical
ISRG
|
+$9.53M |
| 5 |
Stryker
SYK
|
+$9.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.33% |
| 2 | Financials | 21.57% |
| 3 | Communication Services | 9.34% |
| 4 | Consumer Discretionary | 9.26% |
| 5 | Healthcare | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Privia Health
PRVA
$3.31B
| – | – |
-99,140
| Closed | -$1.94M |
|
152
Quanterix
QTRX
$184M
| – | – |
-81,610
| Closed | -$1.92M |
|
153
Roper Technologies
ROP
$36.6B
| – | – |
-7,820
| Closed | -$4.39M |
|
154
Reliance Steel & Aluminium
RS
$19.6B
| – | – |
-2,417
| Closed | -$808K |
|
155
Steris
STE
$20.9B
| – | – |
-18,270
| Closed | -$4.11M |
|
156
Toyota
TM
$211B
| – | – |
-1,408
| Closed | -$354K |
|
157
Thermo Fisher Scientific
TMO
$196B
| – | – |
-15,590
| Closed | -$9.06M |
|
158
Tenaris
TS
$28.3B
| – | – |
-16,691
| Closed | -$655K |
|
159
Veeva Systems
VEEV
$32.1B
| – | – |
-22,020
| Closed | -$5.1M |
|
160
Veralto
VLTO
$22.9B
| – | – |
-8,566
| Closed | -$759K |
|
161
West Pharmaceutical
WST
$24.9B
| – | – |
-12,160
| Closed | -$4.81M |
|
162
XP
XP
$8.68B
| – | – |
-32,191
| Closed | -$826K |
|
163
Zoetis
ZTS
$31.9B
| – | – |
-21,010
| Closed | -$3.56M |
|
164
Astrana Health
ASTH
$2.21B
| – | – |
-42,490
| Closed | -$1.78M |
|
|
ACCD
165
DELISTED
Accolade Inc
ACCD
| – | – |
-110,250
| Closed | -$1.16M |
|
Similar funds
GIM
PRC
PWS
SCM
IFAM
JWM
TWM
AT
McKinley Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, McKinley Capital Management held 165 positions worth $571M, down 31% from $833M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
McKinley Capital Management withdrew a net $297M in Q2 2024, closing 50 positions and reducing 80 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $9.06M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.
Against the trend, McKinley Capital Management opened a new position in Agnico Eagle Mines worth $2.53M.
- McKinley Capital Management's largest Q2 2024 buy was Agnico Eagle Mines: 38,631 shares worth $2.53M.
- McKinley Capital Management added most to Southern Copper in Q2 2024, an estimated $2.74M increase.
- McKinley Capital Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $11.2M.
- McKinley Capital Management fully exited Thermo Fisher Scientific in Q2 2024, selling an estimated $9.06M.
- McKinley Capital Management's ten largest holdings make up 43% of its $571M portfolio in Q2 2024.
- McKinley Capital Management opened 2 new positions and closed 50 in Q2 2024.
- McKinley Capital Management's portfolio value fell 31% quarter-over-quarter to $571M.
Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.